Related Articles
Characteristics of sphingomyelin metabolism in the MCF7 and BT474 radiotherapy‑resistant HER2‑positive breast cancer cell lines
Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report
Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy
Clinical significance of sHER2‑ECD and calpain‑10 expression in tumor tissues of patients with breast cancer
Phospho-PRAS40Thr246 predicts trastuzumab response in patients with HER2-positive metastatic breast cancer